2.525
price down icon0.59%   -0.005
 
loading
前日終値:
$2.53
開ける:
$2.55
24時間の取引高:
405.09K
Relative Volume:
0.59
時価総額:
$129.37M
収益:
$488.00K
当期純損益:
$-41.44M
株価収益率:
-2.8056
EPS:
-0.9
ネットキャッシュフロー:
$-31.47M
1週間 パフォーマンス:
-11.44%
1か月 パフォーマンス:
-9.21%
6か月 パフォーマンス:
-28.95%
1年 パフォーマンス:
+118.70%
1日の値動き範囲:
Value
$2.465
$2.59
1週間の範囲:
Value
$2.465
$2.88
52週間の値動き範囲:
Value
$1.13
$6.42

Cardiff Oncology Inc Stock (CRDF) Company Profile

Name
名前
Cardiff Oncology Inc
Name
セクター
Healthcare (1195)
Name
電話
858-952-7570
Name
住所
11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Name
職員
32
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
CRDF's Discussions on Twitter

CRDF を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CRDF 2.51 129.37M 488.00K -41.44M -31.47M -0.90
VRTX 449.22 115.43B 10.63B -479.80M -1.35B 13.33
REGN 745.90 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 595.75 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.14 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 108.17 24.89B 3.30B -501.07M 1.03B 11.54

Cardiff Oncology Inc Stock (CRDF) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2022-01-05 開始されました William Blair Outperform
2021-12-08 開始されました Robert W. Baird Outperform
2021-08-09 再開されました Maxim Group Buy
2020-10-22 開始されました H.C. Wainwright Buy
2020-10-08 開始されました Piper Sandler Overweight

Cardiff Oncology Inc (CRDF) 最新ニュース

pulisher
Nov 20, 2024

Cardiff Oncology secures patent for cancer drug combo - Investing.com India

Nov 20, 2024
pulisher
Nov 20, 2024

Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC - GlobeNewswire

Nov 20, 2024
pulisher
Nov 19, 2024

CRDFCardiff Oncology, Inc. Latest Stock News & Market Updates - StockTitan

Nov 19, 2024
pulisher
Nov 19, 2024

Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS ... - News-Press Now

Nov 19, 2024
pulisher
Nov 19, 2024

Cardiff Oncology Secures Patent for Cancer Drug Combo Through 2043 | CRDF Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 12, 2024

Cardiff Oncology: Q3 Earnings Snapshot - AOL

Nov 12, 2024
pulisher
Nov 09, 2024

HC Wainwright Has Lowered Expectations for Cardiff Oncology (NASDAQ:CRDF) Stock Price - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Cardiff Oncology Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 09, 2024
pulisher
Nov 08, 2024

Cardiff Oncology Reports Positive Q3 2024 Results and Clinical Progress - TipRanks

Nov 08, 2024
pulisher
Nov 08, 2024

Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates - MSN

Nov 08, 2024
pulisher
Nov 07, 2024

Cardiff Oncology Reports 7.7x Better Results in Phase 2 Cancer Trial, $57.7M Cash Position | CRDF Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 07, 2024

Cardiff Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Cardiff Oncology: Some Data Are In; Here's What You Should Know And Look For Next - Seeking Alpha

Nov 07, 2024
pulisher
Nov 03, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Nov 03, 2024
pulisher
Nov 02, 2024

Cardiff Oncology (FRA:XE7C) Float Percentage Of Total Shares Outstanding : 97.27% (As of Nov. 02, 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Nov 01, 2024

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Up 7.2% in October - MarketBeat

Nov 01, 2024
pulisher
Oct 30, 2024

Cardiff Oncology Announces Journal of Clinical Oncology - GlobeNewswire

Oct 30, 2024
pulisher
Oct 30, 2024

Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - StockTitan

Oct 30, 2024
pulisher
Oct 29, 2024

Alley Investment Management Company LLC Purchases New Stake in NVIDIA Co. (NASDAQ:NVDA) - Defense World

Oct 29, 2024
pulisher
Oct 25, 2024

NA Liquid Biopsy Market 2024 To Witness Amazing Growth By 2032 - openPR

Oct 25, 2024
pulisher
Oct 24, 2024

3 US Penny Stocks With Market Caps Over $40M - Simply Wall St

Oct 24, 2024
pulisher
Oct 22, 2024

JAK Inhibitors Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 50+ Companies Working in the Domain - The Malaysian Reserve

Oct 22, 2024
pulisher
Oct 15, 2024

KRAS Inhibitors Market Poised to Reach $157.6 Million by 2031, Driven by 5.61% CAGR As Revealed In New Report - WhaTech

Oct 15, 2024
pulisher
Oct 14, 2024

Will Cardiff Oncology's Onvansertib Data Boost Its Stock Price? - RTTNews

Oct 14, 2024
pulisher
Oct 10, 2024

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Appears Robust With 90+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Malaysian Reserve

Oct 10, 2024
pulisher
Oct 10, 2024

Cardiff Oncology Inc’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Oct 10, 2024
pulisher
Oct 09, 2024

Cardiff Oncology Inc (CRDF) Q2 2024 Earnings Call Highlights: Strategic Trials and Financial ... - Yahoo Finance

Oct 09, 2024
pulisher
Oct 09, 2024

Neuroendocrine Tumors Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - Barchart

Oct 09, 2024
pulisher
Oct 09, 2024

We're Keeping An Eye On Cardiff Oncology's (NASDAQ:CRDF) Cash Burn Rate - Simply Wall St

Oct 09, 2024
pulisher
Oct 08, 2024

Its Stock Has Paid Off Big Time For Cardiff Oncology Inc - SETE News

Oct 08, 2024
pulisher
Oct 07, 2024

Stock Performance Spotlight: Cardiff Oncology Inc (CRDF) Ends the Day at 2.60, Up by 2.77 - The Dwinnex

Oct 07, 2024
pulisher
Oct 07, 2024

CRDF (Cardiff Oncology Inc) has impressive results - US Post News

Oct 07, 2024
pulisher
Oct 04, 2024

Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market - Seeking Alpha

Oct 04, 2024
pulisher
Oct 03, 2024

Take off with Cardiff Oncology Inc (CRDF): Get ready for trading - SETE News

Oct 03, 2024
pulisher
Oct 02, 2024

Market Insight: Cardiff Oncology Inc (CRDF)’s Notable Drop, Closing at 2.47 - The Dwinnex

Oct 02, 2024
pulisher
Oct 02, 2024

How to interpret Cardiff Oncology Inc (CRDF)’s stock chart patterns - US Post News

Oct 02, 2024
pulisher
Oct 02, 2024

PLK-1 Inhibitors Market to Register Immense Growth by 2034 | DelveInsight - The Malaysian Reserve

Oct 02, 2024
pulisher
Oct 01, 2024

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Sunbelt Securities Inc. - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

KRAS Inhibitors Market: New Treatments Are Set to Change Cancer Care | DelveInsight - 新浪香港

Sep 30, 2024
pulisher
Sep 27, 2024

IGC Pharma, Inc. (NYSEMKT:IGC) Director Buys $199,999.90 in Stock - Defense World

Sep 27, 2024
pulisher
Sep 26, 2024

Blair William & Co. IL Raises Stake in Cardiff Oncology, Inc. (NASDAQ:CRDF) - Defense World

Sep 26, 2024
pulisher
Sep 26, 2024

Delta Investment Management LLC Cuts Stock Position in JPMorgan Ultra-Short Income ETF (NYSEARCA:JPST) - Defense World

Sep 26, 2024
pulisher
Sep 25, 2024

Cardiff City . . . The Doom Loop Club Stuck On Groundhog Day - Dai Sport

Sep 25, 2024
pulisher
Sep 25, 2024

Investment Opportunities: Capitalizing on the Global Kras - openPR

Sep 25, 2024
pulisher
Sep 25, 2024

Cardiff City need 'long-term strategy' after Erol Bulut exitRob Earnshaw - BBC.com

Sep 25, 2024
pulisher
Sep 24, 2024

Tonight's Cardiff City news as 'stunned' club release statement and pundit picks 'fantastic' fit for job - Yahoo News UK

Sep 24, 2024
pulisher
Sep 24, 2024

Trading Day Review: Cardiff Oncology Inc (CRDF) Loses Momentum, Closing at 2.58 - The Dwinnex

Sep 24, 2024

Cardiff Oncology Inc (CRDF) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):